During the past decade, Oncology Institute for Hope and Innovation conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Oncology Institute for Hope and Innovation" #1 collaborator was "Patient-Centered Outcomes Research Institute" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Oncology Institute for Hope and Innovation" are "Cancer" (2 trials) and "End of Life" (2 trials). Many other conditions were trialed in "Oncology Institute for Hope and Innovation" in a lesser frequency.

Most popular intervention types in "Oncology Institute for Hope and Innovation" are "Behavioral" (2 trials) and "Other" (2 trials). Other intervention types were less common.

The name of intervention was led by "Program participants" (1 trials), "Receive redesigned team-based supportive cancer care" (1 trials), "Receive technology-based supportive cancer care" (1 trials) and "Usual Care" (1 trials). Other intervention names were less common.

The vast majority of trials in "Oncology Institute for Hope and Innovation" are 2 trials for "All" genders.

Currently, there are NaN active trials in "Oncology Institute for Hope and Innovation". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 1 completed trials in Oncology Institute for Hope and Innovation, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Oncology Institute for Hope and Innovation, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".